Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery. Incorporating and building on the successes of the Vanderbilt Program in Drug Discovery, the new center will look to accelerate research that may lead to new treatments for Parkinson’s disease, schizophrenia and other brain disorders.
The center is co-directed by Jeffrey Conn and Craig Lindsley. Other members include J. Scott Daniels, Carrie Jones and Colleen Niswender. Read more about the center and its research at this link.